Thursday, November 12, 2026

Period Poverty and Struggle for Adequate Menstrual Products

Loannie Dao

January 19, 2018

Homeless girl in New York. Image by: Bustle.
NEW YORK (ViaNews) – Millions of women and girls living in poverty are placed in a crisis situation every month when they get their periods. For this select population, gaining access to sanitary products becomes a balancing act, forcing them to choose between food or hygiene. According to Jennifer Weiss-Wolf, author of Periods Gone Public: Taking a Stand for Menstrual Equity, the ability to access sanitary products affects a person’s freedom to work and study, to be healthy, and to participate in daily life with basic dignity. Period poverty is the lack of access to sanitary products due to financial constraints. While the United Nations has recognized menstrual hygiene as a human-rights issue, for millions of women and girls the problem is far from achieving a resolution. The issue is a reality for millions of women and girls, not just in developing countries but in the most unexpected nations such as the United States and the United Kingdom. In recent years, the US and the UK are shedding light on the problem. A survey by Plan International found that one in ten women and girls ages 14 to 21 are not able to afford sanitary products. Further, the average cost per package of pads and tampons in the US are $5.84 and $7.62 respectively. Comparatively, according to Feeding America, the average cost of a basic meal is $2.94. These figures show that the cost of providing sanitary products are typically higher than what most people fork up for an average meal. The lack of access to adequate menstrual hygiene care is not just a human-rights issue but a global public health problem. For instance, complications in health arise when women and girls do not have the resource to change their tampons often, causing them to wear them for too long, resulting in infections, and leading to toxic shock syndrome. Caused by bacterial toxins that affect menstruating women, toxic shock syndrome is a condition commonly seen in those who use super-absorbent tampons. The female body responds with a sharp drop in blood pressure that deprives organs of oxygen and can lead to death. Women alone are already at a disadvantage when it comes to equal access to basic needs. In the US alone, nearly 39.7% of all homeless people are women and almost 50,000 women are unsheltered and living in the streets. It is no surprise that the most vulnerable population are homeless women. For many, the topic of menstruation is a taboo subject, making it difficult to ask for help when it is needed. Weiss-Wolf writes that low-income teenage girls often experienced embarrassment about their first periods and have a desire to know more about the process of menstruation. The study also shows that low-income girls in the United States are unprepared for puberty and have largely negative experiences in their transition which perpetuates the stigma. In many regions, menstruating girls drop out of school due to the stigma of menstruation and/or a lack of resources. Even in today’s age, girls are missing school every month because they cannot afford sanitary products. Because period poverty is an unavoidable matter for many women and girls, advocates are pushing for change. In the past year, a proposal to remove the “tampon tax” has been introduced in the state of New York. The state legislature recently approved a bill to remove all taxes on menstrual products and Governor Cuomo is expected to sign the bill into law. Additionally, in 2016, Mayor Bill de Blasio signed legislation to make menstrual products accessible in all New York City public schools, shelters and jails free. The plan will further ensure that menstrual products are readily available to nearly 23,000 women and 300,000 girls. According to the city council, the pass will solidify New York City as the first municipality in the nation to proactively guarantee access to menstrual hygiene products. https://www.youtube.com/watch?v=ABch4VYOJZ0
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,565 source documents archived
Query this data → isubstrate.com